PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.92%
Revenue growth under 50% of 3391.T's 17.54%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.15%
Gross profit growth under 50% of 3391.T's 18.14%. Michael Burry would be concerned about a severe competitive disadvantage.
32.84%
EBIT growth below 50% of 3391.T's 4204.80%. Michael Burry would suspect deeper competitive or cost structure issues.
28.75%
Positive operating income growth while 3391.T is negative. John Neff might view this as a competitive edge in operations.
25.93%
Net income growth under 50% of 3391.T's 1196.26%. Michael Burry would suspect the firm is falling well behind a key competitor.
25.93%
EPS growth under 50% of 3391.T's 1196.24%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
25.93%
Diluted EPS growth under 50% of 3391.T's 1193.88%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
142.00%
10Y revenue/share CAGR at 75-90% of 3391.T's 167.68%. Bill Ackman would press for new markets or product lines to narrow the gap.
46.86%
5Y revenue/share CAGR similar to 3391.T's 46.66%. Walter Schloss might see both companies benefiting from the same mid-term trends.
31.11%
3Y revenue/share CAGR similar to 3391.T's 34.21%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
182.37%
Net income/share CAGR above 1.5x 3391.T's 44.89% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
44.64%
5Y net income/share CAGR above 1.5x 3391.T's 12.67%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
51.81%
3Y net income/share CAGR 1.25-1.5x 3391.T's 42.16%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
304.14%
10Y equity/share CAGR above 1.5x 3391.T's 115.47%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
79.56%
5Y equity/share CAGR above 1.5x 3391.T's 24.05%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.29%
3Y equity/share CAGR above 1.5x 3391.T's 7.19%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
62.50%
3Y dividend/share CAGR of 62.50% while 3391.T is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-1.61%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-6.17%
Inventory is declining while 3391.T stands at 0.68%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.56%
Negative asset growth while 3391.T invests at 5.31%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.19%
Positive BV/share change while 3391.T is negative. John Neff sees a clear edge over a competitor losing equity.
11.12%
Debt shrinking faster vs. 3391.T's 36.91%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-1.84%
We cut SG&A while 3391.T invests at 21.44%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.